Does Preoperative Bowel Preparation Reduce Surgical Site Infections During Elective Ventral Hernia Repair? - 19/04/17
, Ivy N. Haskins, MD a, Sharon Phillips, MSPH b, Ajita S. Prabhu, MD, FACS a, Steven Rosenblatt, MD, FACS a, Benjamin K. Poulose, MD, FACS c, Michael J. Rosen, MD, FACS aAbstract |
Background |
To date, little is known about the benefits of preoperative bowel preparation in patients undergoing elective ventral hernia repair (VHR). The purpose of this study was to determine the effect of preoperative bowel preparation on 30-day wound events in patients undergoing elective VHR using the Americas Hernia Society Quality Collaborative (AHSQC).
Study Design |
All patients undergoing elective VHR from January 2013 through January 2016 were identified within the AHSQC. Patients undergoing emergency VHR and those with a CDC wound class IV were excluded from our analysis. Patients were divided into 2 groups: Clean (CDC wound class I) and Contaminated (CDC wound classes II and III). The association of preoperative bowel preparation with 30-day wound events was investigated using logistic regression modeling.
Results |
A total of 3,709 patients met inclusion criteria; 3,101 (83.6%) had CDC wound class I, and 608 (16.4%) had CDC wound classes II or III. Within the Clean group, patients who underwent preoperative bowel preparation were significantly more likely to experience a surgical site infection (SSI), surgical site occurrence (SSO), and surgical site occurrence requiring procedural intervention (SSOPI). Within the Contaminated group, patients who underwent preoperative bowel preparation were significantly more likely to experience an SSOPI.
Conclusions |
The use of preoperative bowel preparation in patients undergoing elective VHR does not reduce the risk of 30-day wound events.
Il testo completo di questo articolo è disponibile in PDF.Abbreviations and Acronyms : AHSQC, BP, MBP, OAP, SSI, SSO, SSOPI, VHR
Mappa
| CME questions for this article available at jacscme.facs.org |
|
| Disclosure Information: Authors have nothing to disclose. Timothy J Eberlein, Editor-in-Chief, has nothing to disclose. |
|
| Disclosures outside the scope of this work: Dr Poulose is a paid consultant to Ariste Medical and Pfizer and receives grant funding from Bard Davol. Dr Prabhu receives grant funding from Intuitive Surgical and is a paid consultant to Bard Davol and Covidien. Dr Rosen receives grant funding from Miromatrix and receives payment for lectures from Bard Davol and Gore Medical. |
|
| Support: Dr Poulose is a paid employee of Americas Hernia Society Quality Collaborative (AHSQC) and Dr Rosen receives salary support as Medical Director of AHSQC. |
Vol 224 - N° 2
P. 204-211 - febbraio 2017 Ritorno al numero
Articolo precedente
- Does Management of True Aneurysms of Peripancreatic Arteries Require Repair of Associated Celiac Artery Stenosis?
- Julia M. Boll, Kenneth W. Sharp, C. Louis Garrard, Thomas C. Naslund, John A. Curci, R. James Valentine
- Massive Localized Lymphedema: A Case-Control Study
- Reid A. Maclellan, David Zurakowski, Frederick D. Grant, Arin K. Greene
Benvenuto su EM|consulte, il riferimento dei professionisti della salute.
L'accesso al testo integrale di questo articolo richiede un abbonamento.
Già abbonato a @@106933@@ rivista ?